Anika Therapeutics (ANIK) Times Interest Earned (2020)

Anika Therapeutics (ANIK) reported Times Interest Earned of -$19.95 for Q4 2020.

Anika Therapeutics (ANIK) Times Interest Earned (2020) Analysis & Trends

Anika Therapeutics (ANIK) has 1 years of Times Interest Earned data on file, last reported at -$19.95 in Q4 2020.

  • Times Interest Earned for Q4 2020 came in at -$19.95, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was -$31.47 (changed N/A YoY), and the FY2020 annual result was -$31.47, changed N/A from the prior year.
  • Times Interest Earned steadied at -$19.95 in Q4 2020 per ANIK's latest filing.
  • Over five years, Times Interest Earned peaked at -$19.95 in Q4 2020 and troughed at -$19.95 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 13.44
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 108.60
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 5.39
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.31
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 16.72
10 Anika Therapeutics 197.89 Mn 131.10 Mn 19.00 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2020 -19.95